Literature DB >> 22917857

Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline.

Manolo Casagrande1, Anna Barteselli, Nicoletta Basilico, Silvia Parapini, Donatella Taramelli, Anna Sparatore.   

Abstract

With the aim to investigate the effect of different heterocyclic rings linked to the 4-aminoquinoline nucleus on the antimalarial activity, a set of 7-chloro-N-(heteroaryl)-methyl-4-aminoquinoline and 7-chloro-N-(heteroaryl)-4-aminoquinoline was synthesized and tested in vitro against D-10 (CQ-S) and W-2 (CQ-R) strains of Plasmodium falciparum. All compounds exhibited from moderate to high antiplasmodial activities. The activity was strongly influenced both by the presence of a methylenic group, as a spacer between the 4-aminoquinoline and the heterocyclic ring, and by the presence of a basic head. The most potent molecules inhibited the growth of both CQ-S and CQ-R strains of P. falciparum with IC(50)<30 nM and were not toxic against human endothelial cells. These results confirm that the presence of an heteroaryl moiety in the side chain of 7-chloro-4-aminoquinoline is useful for the design and development of new powerful antimalarial agents.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22917857     DOI: 10.1016/j.bmc.2012.07.040

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.

Authors:  Andrii Monastyrskyi; Napon Nilchan; Victor Quereda; Yoshihiko Noguchi; Claudia Ruiz; Wayne Grant; Michael Cameron; Derek Duckett; William Roush
Journal:  Bioorg Med Chem       Date:  2017-12-15       Impact factor: 3.641

2.  Synthesis of New 4-Aminoquinolines and Evaluation of Their In Vitro Activity against Chloroquine-Sensitive and Chloroquine-Resistant Plasmodium falciparum.

Authors:  Chandima S K Rajapakse; Maryna Lisai; Christiane Deregnaucourt; Véronique Sinou; Christine Latour; Dipankar Roy; Joseph Schrével; Roberto A Sánchez-Delgado
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

3.  Antiplasmodial activity of chloroquine analogs against chloroquine-resistant parasites, docking studies and mechanisms of drug action.

Authors:  Nicolli B de Souza; Arturene M L Carmo; Adilson D da Silva; Tanos C C França; Antoniana U Krettli
Journal:  Malar J       Date:  2014-12-02       Impact factor: 2.979

4.  Anti-Mycobacterial Evaluation of 7-Chloro-4-Aminoquinolines and Hologram Quantitative Structure-Activity Relationship (HQSAR) Modeling of Amino-Imino Tautomers.

Authors:  Marcelle L F Bispo; Camilo H S Lima; Laura N F Cardoso; André L P Candéa; Flávio A F M Bezerra; Maria C S Lourenço; Maria G M O Henriques; Ricardo B Alencastro; Carlos R Kaiser; Marcus V N Souza; Magaly G Albuquerque
Journal:  Pharmaceuticals (Basel)       Date:  2017-06-09

5.  Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents.

Authors:  Tim Van de Walle; Maya Boone; Julie Van Puyvelde; Jill Combrinck; Peter J Smith; Kelly Chibale; Sven Mangelinckx; Matthias D'hooghe
Journal:  Eur J Med Chem       Date:  2020-04-23       Impact factor: 6.514

6.  Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.

Authors:  Niteen A Vaidya; Renu Vyas
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

7.  Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and in vitro assays.

Authors:  Silvia Parapini; Piero Olliaro; Visweswaran Navaratnam; Donatella Taramelli; Nicoletta Basilico
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.